These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26647152)

  • 21. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases.
    De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
    Surgery; 2016 Jan; 159(1):70-6. PubMed ID: 26456123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
    Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
    Trimboli P; Giovanella L
    Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
    Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
    J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can procalcitonin be useful for medullary thyroid cancer?
    Kaczka K; Mikosiński S; Fendler W; Jałocha-Kaczka A; Pomorski L
    Endokrynol Pol; 2010; 61(5):430-6. PubMed ID: 21049453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma.
    Yokoi K; Imai T; Shibata A; Hibi Y; Kikumori T; Funahashi H; Nakao A
    Endocr J; 2003 Aug; 50(4):453-8. PubMed ID: 14599120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer.
    Andrade F; Rondeau G; Boucai L; Zeuren R; Shaha AR; Ganly I; Vaisman F; Corbo R; Tuttle M
    Arch Endocrinol Metab; 2019; 63(2):137-141. PubMed ID: 30916162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
    Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
    Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Challenges of Medullary Thyroid Carcinoma.
    Leimbach RD; Hoang TD; Shakir MKM
    Oncology; 2021; 99(7):422-432. PubMed ID: 33878761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary thyroid nodules by measurement of calcitonin (Ct) in aspiration needle washout in patients with multinodular goiter and moderately elevated serum Ct.
    Trimboli P; Nigri G; Romanelli F; Cicciarella Modica DD; Crescenzi A; Valabrega S; Giovanella L
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):234-7. PubMed ID: 22328107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
    Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
    J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
    Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
    J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
    Lim SK; Guéchot J; Vaubourdolle M
    Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
    Bolko P; Manuszewska-Jopek E; Michałek K; Waśko R; Jaskuła M; Sowiński J
    Arch Immunol Ther Exp (Warsz); 2003; 51(6):415-9. PubMed ID: 14692663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Treatment of Medullary Thyroid Cancer.
    Machens A; Dralle H
    Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
    Fugazzola L
    Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
    [No Abstract]   [Full Text] [Related]  

  • 39. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical spectrum of RET proto-oncogene mutations in codon 790.
    Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
    Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.